Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

Comparative Effectiveness Review Number 219: Antipsychotics For The Prevention And Treatment Of Delirium

On July 16, 2019, the Agency for Healthcare Research and Quality (AHRQ) released this comparative effectiveness review on using antipsychotics for the prevention and treatment of delirium. The review assess benefits and harms of using antipsychotics for the prevention and treatment of delirium in adult patient populations and includes an abstract, findings, and information on the data source used . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: